Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical and Biological Characterization of Children with FLT3ITD Mutated Acute Myeloid Leukemia (AML): A Report from the AIEOP AML-2002 Study Group

Elena Manara, PhD, Valeria Bisio, BS, Marco Frison, MD, Katia Polato, Claudia Tregnago, PhD, Barbara Buldini, MD, Riccardo Masetti, MD, Roberto Rondelli, MD, Gianni Cazzaniga, PhD, Andrea Biondi, Prof, MD, Franco Locatelli, Prof, MD PhD, Martina Pigazzi, PhD, Giuseppe Basso, Prof, MD

Blood (2015) 126 (23): 3845.

https://doi.org/10.1182/blood.V126.23.3845.3845

Published: 2015

Journal Articles

Children with Acute Leukemia Given Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Compatible Sibling, or an Unrelated Donor (UD) or an HLA-Haploidentical Relative after Alpha/Beta T-Cell Depletion Have a Comparable Outcome

Alice Bertaina, MDPhD, Barbarella Lucarelli, MD, Riccardo Masetti, MD, Pietro Merli, MD, Roberto Rondelli, MD, Giuseppina Li Pira, PhD, Marco Andreani, PhD, Lavinia Grapulin, MD, Daniela Pende, MD, Michela Falco, PhD, Maria Rita Pinto, MD, Valentina Bertaina, PhD, Maria Teresa Romano, MD, Stefano Ceccarelli, MD, Letizia Pomponia Brescia, MD, Daria Pagliara, MD, Alessandro Moretta, MD, Lorenzo Moretta, MD, Franco Locatelli, Prof, MD PhD

Blood (2015) 126 (23): 195.

https://doi.org/10.1182/blood.V126.23.195.195

Published: 2015

Journal Articles

Intravenous (i.v.) or Oral (os) Busulphan (BUS) in Children Prior to Autologous (Auto) or Allogeneic (Allo) Stem Cell Transplantation (SCT): Pharmacokinetics (PK), Toxicity and Compliance.

Arcangelo Prete, MD, Antonella Bartoli, MD, Claudia Castellini, MD, Roberto Rondelli, MD, Riccardo Masetti, MD, Andrea Pession, MD, Mario Regazzi-Bonora, MD

Blood (2005) 106 (11): 5320.

https://doi.org/10.1182/blood.V106.11.5320.5320

Published: 2005

Journal Articles

High Dose Therapy (HDCT) and Autologous Haematopoietic Stem Cell Transplantation (aSCT) in Paediatric Patients with Recurrent or Refractory Hodgkin’s Disease (HD): Results and Outcome.

Arcangelo Prete, MD, Federico Bonetti, MD, Roberto Rondelli, MD, Simone Cesaro, MD, Sandro Dallorso, MD, Claudio Favre, MD, Franca Fagioli, MD, Chiara Messina, MD, Roberta Burnelli, MD, Franco Locatelli, MD, Andrea Pession, MD

Blood (2005) 106 (11): 2088.

https://doi.org/10.1182/blood.V106.11.2088.2088

Published: 2005

Journal Articles

Outcome of Children with All Given HSCT from Unrelated Volunteers Has Significantly Improved over Time and Now Is Comparable to That of Children Transplanted from an HLA-Identical Sibling.

Franco Locatelli, MD, Marco Zecca, MD, Andrea Pession, MD, Cornelio Uderzo, MD, Giorgio Dini, MD, Franca Fagioli, MD, Claudio Favre, MD, Valentino Conter, MD, Roberto Rondelli, MD, Federico Bonetti, MD, Chiara Messina, MD

Blood (2004) 104 (11): 2156.

https://doi.org/10.1182/blood.V104.11.2156.2156

Published: 2004

NARROW

Clinical and Biological Characterization of Children with FLT3ITD Mutated Acute Myeloid Leukemia (AML): A Report from the AIEOP AML-2002 Study Group

Children with Acute Leukemia Given Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Compatible Sibling, or an Unrelated Donor (UD) or an HLA-Haploidentical Relative after Alpha/Beta T-Cell Depletion Have a Comparable Outcome

Intravenous (i.v.) or Oral (os) Busulphan (BUS) in Children Prior to Autologous (Auto) or Allogeneic (Allo) Stem Cell Transplantation (SCT): Pharmacokinetics (PK), Toxicity and Compliance.

High Dose Therapy (HDCT) and Autologous Haematopoietic Stem Cell Transplantation (aSCT) in Paediatric Patients with Recurrent or Refractory Hodgkin’s Disease (HD): Results and Outcome.

Outcome of Children with All Given HSCT from Unrelated Volunteers Has Significantly Improved over Time and Now Is Comparable to That of Children Transplanted from an HLA-Identical Sibling.

Email alerts

ASH Publications

American Society of Hematology

Clinical and Biological Characterization of Children with FLT3ITD Mutated Acute Myeloid Leukemia (AML): A Report from the AIEOP AML-2002 Study Group

Children with Acute Leukemia Given Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Compatible Sibling, or an Unrelated Donor (UD) or an HLA-Haploidentical Relative after Alpha/Beta T-Cell Depletion Have a Comparable Outcome

Intravenous (i.v.) or Oral (os) Busulphan (BUS) in Children Prior to Autologous (Auto) or Allogeneic (Allo) Stem Cell Transplantation (SCT): Pharmacokinetics (PK), Toxicity and Compliance.

High Dose Therapy (HDCT) and Autologous Haematopoietic Stem Cell Transplantation (aSCT) in Paediatric Patients with Recurrent or Refractory Hodgkin’s Disease (HD): Results and Outcome.

Outcome of Children with All Given HSCT from Unrelated Volunteers Has Significantly Improved over Time and Now Is Comparable to That of Children Transplanted from an HLA-Identical Sibling.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only